Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection
Clinical trial NCT04385095 · COMPLETED
Trial details
- NCT number
- NCT04385095
- Sponsor
- Synairgen Research Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-16
- Primary completion
- 2021-02-17
- Enrollment
- 221
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.